Literature DB >> 30072004

Impaired Renal Function on Cholesterol Efflux Capacity, HDL Particle Number, and Cardiovascular Events.

Shahzad Chindhy, Parag Joshi, Amit Khera, Colby R Ayers, S Susan Hedayati, Anand Rohatgi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30072004      PMCID： PMC6152844          DOI： 10.1016/j.jacc.2018.05.043

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  5 in total

1.  HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney Disease.

Authors:  Lucie Bauer; Sabine Kern; Kyrill S Rogacev; Insa E Emrich; Adam Zawada; Danilo Fliser; Akos Heinemann; Gunnar H Heine; Gunther Marsche
Journal:  J Am Coll Cardiol       Date:  2017-01-17       Impact factor: 24.094

2.  High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).

Authors:  Rachel H Mackey; Philip Greenland; David C Goff; Donald Lloyd-Jones; Christopher T Sibley; Samia Mora
Journal:  J Am Coll Cardiol       Date:  2012-07-11       Impact factor: 24.094

3.  HDL cholesterol efflux capacity and incident cardiovascular events.

Authors:  Anand Rohatgi; Amit Khera; Jarett D Berry; Edward G Givens; Colby R Ayers; Kyle E Wedin; Ian J Neeland; Ivan S Yuhanna; Daniel R Rader; James A de Lemos; Philip W Shaul
Journal:  N Engl J Med       Date:  2014-11-18       Impact factor: 91.245

4.  High density lipoprotein (HDL) particles from end-stage renal disease patients are defective in promoting reverse cholesterol transport.

Authors:  Josephine L C Anderson; Thomas Gautier; Niels Nijstad; Markus Tölle; Mirjam Schuchardt; Markus van der Giet; Uwe J F Tietge
Journal:  Sci Rep       Date:  2017-02-02       Impact factor: 4.379

5.  Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.

Authors:  L Parker Gregg; Beverley Adams-Huet; Xilong Li; Gates Colbert; Nishank Jain; James A de Lemos; S Susan Hedayati
Journal:  J Am Heart Assoc       Date:  2017-07-05       Impact factor: 5.501
  5 in total
  6 in total

Review 1.  Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations.

Authors:  Heidi Noels; Michael Lehrke; Raymond Vanholder; Joachim Jankowski
Journal:  Nat Rev Nephrol       Date:  2021-05-10       Impact factor: 28.314

2.  Cholesterol Efflux Capacity and Its Association With Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis.

Authors:  Jane J Lee; Gerald Chi; Clara Fitzgerald; Syed Hassan A Kazmi; Arzu Kalayci; Serge Korjian; Danielle Duffy; Alka Shaunik; Bronwyn Kingwell; Robert W Yeh; Deepak L Bhatt; C Michael Gibson
Journal:  Front Cardiovasc Med       Date:  2021-12-13

Review 3.  Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?

Authors:  Susana Coimbra; Flávio Reis; Maria João Valente; Susana Rocha; Cristina Catarino; Petronila Rocha-Pereira; Maria Sameiro-Faria; Elsa Bronze-da-Rocha; Luís Belo; Alice Santos-Silva
Journal:  Biomedicines       Date:  2021-05-16

Review 4.  Current Understanding of the Relationship of HDL Composition, Structure and Function to Their Cardioprotective Properties in Chronic Kidney Disease.

Authors:  Gunther Marsche; Gunnar H Heine; Julia T Stadler; Michael Holzer
Journal:  Biomolecules       Date:  2020-09-21

Review 5.  High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives.

Authors:  Maria Pia Adorni; Nicoletta Ronda; Franco Bernini; Francesca Zimetti
Journal:  Cells       Date:  2021-03-05       Impact factor: 7.666

Review 6.  High-Density Lipoproteins in Kidney Disease.

Authors:  Valentina Kon; Hai-Chun Yang; Loren E Smith; Kasey C Vickers; MacRae F Linton
Journal:  Int J Mol Sci       Date:  2021-07-30       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.